Sponsor Pipeline

Beijing Gene Key Life Technology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-20 NCT07713290 A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular… Phase 1 Active, Not Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07209813 GKL-006 Combined With TACE in Treatment of Unresectable Hepatocellular Carcinoma Hepatocellular Carcinoma Not Yet Recruiting
Phase 1/2
NCT07706855 Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress… ARDS (Acute Respiratory Distress Syndrome) Not Yet Recruiting
Phase 1
NCT07704515 GKL-006Allo Injection in Patients With Advanced Solid Tumors Solid Tumor Malignancies Not Yet Recruiting
NCT07713290 A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular… Hepatocellular Carcinoma (HCC) Active, Not Recruiting
Disease Areas
Get alerts when Beijing Gene Key Life Technology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free